Gene Silencing/Gene Editing
News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics.
ERS Genomics Licenses CRISPR Patents to GenScript Biotech
GenScript said it will use the license to improve its own synthetic sgRNA, gRNA plasmid, gRNA library, and cell line engineering services.
Sherlock Biosciences Foundation Grants License to Rokline Health for COVID-19 CRISPR Tests
Sherlock Biosciences said that under the agreement, Rokline Health will develop and manufacture high-throughput CRISPR kits in the US.
New CRISPR Base Editor Significantly Reduces DNA, RNA Off-Target Mutations
The transformer base editing system is designed for more precise editing, with only background levels of genome-wide and transcriptome-wide off-target edits.
Fetal Hemoglobin Gene Regulation Study Points to Potential Therapeutic Targets
Regulatory elements revealed in the study could potentially be targeted by base editors to treat conditions like sickle cell disease.
Sherlock Bio Foundation Licenses CRISPR Tech to LogicInk
LogicInk said it will use the CRISPR technology to develop an instrument-free diagnostic biosensor for the detection of SARS-CoV-2.